Severe liver disease, acute alcoholism, bronchial asthma, increased intracranial pressure, respiratory depression, patients who have received MAO inhibitors within 14 days, hypotension and during pregnancy and breast-feeding. Pethidine is also contraindicated in patients with a history of hypersensitivity or idiosyncratic response to this drug.